Agreement to Deliver Critical
Medicines
ITASCA,
Ill., Dec. 17, 2024 /PRNewswire/
-- Lakeside Holding Limited ("Lakeside" or the "Company")
(Nasdaq: LSH), a U.S.-based cross-border supply chain solution
provider with a unique focus on the Asia-Pacific market is pleased to announce
that Hupan Pharmaceutical has signed a Sales Agreement (the
"Agreement") with Sinopharm Holding Hubei New Special Medicine Co.,
Ltd. ("Sinopharm Hubei"), a subsidiary of Sinopharm Group. The
Agreement, valued at approximately RMB
11.0 million (approximately $1.5
million), is effective from January 1, 2025, through the end of the year and
involves the sale and delivery of critical medicines,
including Sodium Bicarbonate, Glucose, and Glucose Sodium
Chloride.
This Agreement follows the partnership with Sinopharm Group
announced last month focusing on essential medicine storage,
transportation, and logistics services. These achievements reflect
Hupan Pharmaceutical's expanding role as a reliable provider of
pharmaceutical solutions in China.
"We are excited to strengthen our relationship with Sinopharm
Group further, a leading global player in the healthcare industry,"
said Lan Su, COO of Lakeside Holding
Limited. "This Agreement demonstrates our capabilities in
delivering high-quality pharmaceutical products, ensuring reliable
supplies of essential medicines. We remain committed to
broadening our portfolio and expanding our market
reach, enhancing our role as a trusted pharmaceutical
solutions provider."
About Lakeside Holding Limited
Lakeside Holding Limited is a U.S.-based cross-border supply
chain solution provider with a unique focus on the Asia-Pacific market. Through two specialized
subsidiaries—American Bear Logistics and Hupan Pharmaceutical
(Hubei) Co., Ltd.—Lakeside
delivers tailored logistics solutions spanning general and
specialized sectors.
American Bear Logistics, with strategic hubs in Chicago, Dallas, Los
Angeles, and New York,
offers customized cross-border ocean and airfreight solutions,
connecting Asia-based logistics
service companies and e-commerce platforms with the U.S.
market.
Lakeside recently acquired Hupan Pharmaceutical (Hubei) Co., Ltd., expanding its service scope
and enhancing its pharmaceutical logistics and distribution
capabilities within China. This
strategic move underscores Lakeside's commitment to advancing
integrated cross-border logistics solutions.
For more information, please
visit https://lakeside-holding.com.
Safe Harbor Statement
This press release contains forward-looking statements that
reflect our current expectations and views of future events. Known
and unknown risks, uncertainties and other factors, including those
listed under "Risk Factors," may cause our actual results,
performance or achievements to be materially different from those
expressed or implied by the forward-looking statements. You can
identify some of these forward-looking statements by words or
phrases such as "may," "will," "expect," "anticipate," "aim,"
"estimate," "intend," "plan," "believe," "is/are likely to,"
"potential," "continue" or other similar expressions. We have based
these forward-looking statements largely on our current
expectations and projections about future events that we believe
may affect our financial condition, results of operations, business
strategy and financial needs. These forward-looking statements
involve various risks and uncertainties. Except as required by law,
we undertake no obligation to update or revise publicly any
forward-looking statements, whether as a result of new information,
future events or otherwise, after the date on which the statements
are made or to reflect the occurrence of unanticipated events. We
qualify all of our forward-looking statements by these cautionary
statements.
Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com
View original
content:https://www.prnewswire.com/news-releases/lakeside-signs-1-5-million-sales-agreement-with-sinopharm-group-subsidiary-302333394.html
SOURCE Lakeside Holding Limited